1. Maruti Suzuki: 

This car company rose 2% on March 25 after announcing plans to invest Rs 10,189 crore in a new Gujarat plant with an annual capacity of 2.5 lakh units. The company currently operates at near-full utilisation, with a total capacity of around 25 lakh units.

The new facility will expand capacity by about 10% and help address supply constraints. It will be built in phases, with production expected to begin by 2029. Forecaster expects revenue to grow 18.5% in FY26, while net profit is projected to rise over 10%.

SUVs now account for over half of the passenger vehicle market, and the company’s share in this segment has increased to about 24.5% as of December 2025, up from around 19.5% in FY22. MD and CEO Hisashi Takeuchi said, “We are currently constrained by supply, not demand, and our priority is to scale capacity in line with market growth and exports.”

Exports remain a key growth driver, accounting for about 18% of total sales. The company contributed nearly 46% of India’s passenger vehicle exports in 2025, with export volumes growing over 25% YoY in the first nine months of FY26.

Geopolitical risks remain in the near term. Rising tensions in the Middle East have raised concerns around global trade routes, although the company’s exposure to the region is relatively limited. Senior Executive Rahul Bharti noted, “The Middle East region accounts for about 12.5% of our total exports,” adding that a diversified presence across nearly 100 countries reduces reliance on any single region.

Motilal Oswal reiterated its ‘Buy’ rating on the stock, with a lower target price of Rs 17,406, indicating that a larger portion of earnings growth is expected over the medium term. Margins have been under pressure due to higher discounts, coupled with rising input costs, but are expected to improve as pricing stabilises and the product mix strengthens.

2. Reliance Industries:

This conglomerate has had a dramatic week. Its stock fell 4.6% on Friday after the government imposed a new export tax levy on refineries selling petrol and diesel, adding to the pressure from the semi-annual Nifty 50 index rebalancing that reduced the stock’s weight. Passive funds are expected to withdraw roughly $25 million from the stock. 

The export tax move will squeeze gross refining margins (GRMs), especially as the global crude basket has surged past $100 per barrel due to geopolitical shocks, raising input costs across Reliance’s Jamnagar operations.

Reliance gets the majority of its revenue from its Oil-to-Chemicals (O2C) segment, with refined fuel exports contributing over 55% of overall sales. To drive international growth, the company is backing a historic $300 billion oil refinery development at the Port of Brownsville in Texas, as recently announced by US President Donald Trump.

As oil grows volatile, Reliance is expected to focus more on its consumer and green energy businesses. The company is diversifying fast, launching the first phase of its Dhirubhai Ambani Green Energy “Giga Complex”, with an eye on the multi-billion dollar domestic market for solar modules and green hydrogen.

Reliance has also introduced AI cloud services in India through tech partnerships following its massive data center expansion. While these launches are expected to support growth, the green energy rollout is likely to face intense competition from both early mover domestic and global players.

Management is also exploring acquisitions to strengthen its presence in critical mineral and battery technology markets. Chairman Mukesh Ambani says that the company is “actively pursuing targeted strategic partnerships” and prefers deploying internal cash generation toward acquisitions to scale up the new energy business.

Motilal Oswal has stayed bullish on Reliance despite the volatility in the Middle East (although the title of the report, “chaos can be a catalyst”, is not that encouraging). The brokerage expects near-term pressure in the oil segment, but sees new energy rollouts and telecom tariff hikes supporting long-term growth.

3. Natco Pharma:

This pharmaceutical company rose 2.5% on Wednesday after its board approved the demerger of its agrochemicals business into a separate listed entity. Shareholders will receive one share in the new company for every share held, effective October 1, 2026. Management expects the move to sharpen strategic focus and unlock value, especially as the crop health segment has seen strong growth, with revenue rising nearly 90% YoY in the past quarter.

The company trades at 11.2x earnings, the lowest amongst its peers. The demerger is expected to improve operational flexibility and enable more focused execution across both businesses. Shareholding data indicates that mutual funds have increased their stake over the past two months.

Natco derives most of its revenue from pharmaceuticals, with export formulations forming the largest share. This segment contributes over 75% of sales, driven by strong performance in Brazil, Canada, and other emerging markets. Growth came despite zero contribution from Revlimid, which was earlier a key earnings driver, indicating improving diversification in the base business.

To drive future growth, the company has launched a generic version of Pomalyst, a multiple myeloma treatment with a $3 billion market in the US. It has also introduced semaglutide in India through partnerships following the patent expiry in March. While these launches are expected to support growth, semaglutide is likely to face intense competition from multiple generic players.

Management is also exploring acquisitions to strengthen its presence in emerging markets. CEO Rajeev Nannapaneni said the company is “actively pursuing 2–3 targets” and prefers deploying cash toward acquisitions to scale the business.

Following the announcement, Geojit BNP Paribas raised its rating on the stock to ‘Accumulate’ with a target price of Rs 1,058. The brokerage expects near-term pressure from the decline in Revlimid but sees new launches and acquisitions supporting long-term growth.

4. Brigade Enterprises: 

This realty company jumped 3.9% on March 25 after launching Brigade Belvedere. This new residential project in East Bengaluru has revenue potential of over Rs 1,100 crore and boosts the company’s footprint in the city's IT corridor.

Brigade is expanding beyond homes to become a more versatile developer. On March 10, it entered the industrial real estate sector with a 25-acre park in North Bengaluru, a move designed to generate steady rental income. The 2 million sq. ft. project will cater to logistics, manufacturing, and data centres, tapping into high demand near the airport.

The company's diversification continues. It partnered with Primus Senior Living on three senior housing projects totalling Rs 750 crore. Brigade is also growing its managed workspace business, adding a 550-seat lease in Hyderabad to reach 1.1 lakh sq. ft. of total leased space there.

Trendlyne’s Forecaster predicts revenue will grow 14.4% YoY in Q4FY26. New home launches, solid project execution, and momentum in leasing and hospitality will drive this growth.

Brigade targets 15% annual pre-sales growth through FY27, but hitting this goal depends on getting projects approved on time. Managing Director Pavitra Shankar warned, “If I don't get the approvals… we may not be able to make that number… as we are seeing a 50/50 contribution from existing and new launches,” highlighting that new launches are crucial for growth.

Looking ahead, the company will invest Rs 3,600 crore to double its hotel rooms by FY30. Shankar noted, “The Indian hospitality sector continues to see demand outpacing supply.” This segment provides 10% of total revenue and is boosted by rising occupancy and room rates.

Geojit BNP Paribas keeps its ‘Buy’ rating on the stock. It points to a powerful pipeline of 17 million sq. ft. in new launches to fuel growth. The leasing business remains stable, with 93% occupancy and 4.2 million sq. ft. of new commercial space in development. However, the brokerage warns that court cases at its Chennai project are a key risk.

5. Kalpataru Projects International: 

This construction & engineering company rose 5.5% on March 25 after it secured orders worth Rs 4,439 crore. The orders include building transmission lines and substation projects across India and overseas markets, adding to its execution pipeline.

The company’s order book stands at around Rs 63,300 crore, which means it already has a large portion of future work in hand. It has secured around Rs 19,500 crore of orders so far in FY26 and remains on track to meet its full-year target, with demand staying strong across segments. Forecaster expects revenue to grow over 23% YoY in FY26, while net profit is projected to surge over 56%. 

Executive Director & CEO Manish Mohnot said, “International projects account for around 60-65% of our order book, which helps diversify our business across geographies.” A large part of the order book is also from transmission and buildings segments, which together form about 70% of total orders and typically offer better margins.

In the first nine months of FY26, pre-tax profit margin rose by about 80 bps to 5.3%. This improvement comes as older low-margin projects are completed and a larger share of work shifts to newer orders with better pricing. At the same time, the company is getting paid faster on its projects, which has helped reduce net debt by about 29% to around Rs 2,240 crore.

Anand Rathi reiterated its ‘Buy’ call on the stock with a higher target price of Rs 1,408. The brokerage expects growth to stay strong as execution improves, debt reduces, and a larger share of projects comes from segments that earn higher margins. It also highlighted that most of the order book is already in these higher-margin segments, which gives confidence that profitability can keep improving from here.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.